New oncological therapies
Patients who have a higher risk of infection for the Covid virus, such as blood and cancer patients or those with immunosuppression, may benefit from blood plasma from people who have already been infected with Covid. This plasma therapy is now being tested for its effectiveness, but such approaches may form new approaches in oncology, and new therapies can be developed. This presentation is intended to present the above.